The effects of sex hormone-binding globulin (SHBG) on the secretion of human chorionic gonadotrophin (HCG) and cAMP by cultured human cytotrophoblasts were investigated. Cytotrophoblasts obtained from normal term placentae were cultured in serum-free medium with or without the addition of human SHBG. The presence of SHBG in the medium increased the release of HCG and the accumulation of cAMP. Ligand-free SHBG was able to raise both HCG and cAMP concentrations and the maximal response was observed with 1 nM of the steroid-binding globulin. Addition of either oestradiol or 5α-dihydrotestosterone (DHT) to cultures previously incubated with SHBG in a final molar ratio of 1:10 resulted in a further increase of HCG and cAMP concentrations. This effect was blocked when cultured placental cells were exposed to SHBG that was previously saturated with DHT or when incubated in the presence of steroids only. The results of the present study provide evidence for the in-vitro regulation of HCG secretion by SHBG and further support the concept that this steroid-binding protein may act as a mediator of steroid action at the cellular level. Finally, the increase in cAMP suggests that SHBG receptor located in the surface of syncytiotrophoblast membranes is coupled to adenylate cyclase as part of the G-protein receptor family. Our results may provide new insights into the biological implications of extracellular steroid-binding proteins as well as new perspectives on the endocrinology of pregnancy.
Introduction
The placenta, considered as the main barrier between the mother and the embryo, is an important tissue controlling a diversity of events occurring during gestation. This organ is known to synthesize and secrete a number of proteins. Some proteins, such as human chorionic gonadotrophin (HCG) and placental lactogen, which are secreted to the maternal 1368 © European Society for Human Reproduction and Embryology circulation, are specific to the placenta (Talamantes and Ogren, 1988) . The placenta has functions similar to the endocrine glands and there are structural and functional similarities between this tissue and the endocrine system. Actually, hormonal factors produced by placental tissue regulate the release of trophoblast proteins and steroid hormones mimicking the functional high level of organization of the hypothalamicpituitary-gonadal axis (Krieger, 1982; Ahmed et al., 1991) .
Cytotrophoblasts and syncytiotrophoblasts express the potential of producing several proteins, neurohormones, and hormonal steroids. Indeed, our laboratory demonstrated the placenta as a site of human sex hormone-binding globulin (SHBG) gene expression (Larrea et al., 1993) . The existence of placental SHBG was confirmed by steroid-binding assays, immunohistochemistry, and Northern blot analysis. Immunoreactive SHBG was shown to be present in the cytoplasm of syncytial cells and steady-state polyacrylamide gel electrophoresis and Scatchard plot analyses revealed the presence of a high affinity specific binding component for 5α-dihydrotestosterone (DHT). In man there is a single gene encoding both androgen-binding protein and SHBG which is expressed in the testis and the liver respectively (Hammond et al., 1989) . The physiological role of this protein appears to be regulatory since, in addition to binding and transport of steroid hormones, steroid-binding proteins may also function as hormonal first messenger and/or carriers of steroids to specific cells by interaction with plasma membrane receptors (Bordin and Petra, 1980; Larriva-Sahd et al., 1991; Rosner et al., 1991) .
A number of studies have shown that androgen-binding protein and SHBG bind to plasma membrane receptors of sexsteroid-dependent tissues, and protein membrane interaction appears to mediate signal transduction. The presence of specific androgen-binding protein/SHBG binding sites in human placenta has been previously demonstrated (Krupenko et al., 1990) suggesting that locally produced SHBG might be involved in the release of other placental hormones. This study was undertaken to investigate the effects of human SHBG on the secretion of HCG in primary cultures of human syncytiotrophoblast cells.
Materials and methods

Reagents
Human SHBG was isolated from pooled pregnancy serum collected during pregnancy or at delivery by sequential ammonium sulphate precipitation, androgen affinity chromatography, hydroxylapatite chromatography, and gel filtration as previously described (Larrea et al., 1981; Cheng et al., 1983) . Its purity was verified by analytical sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) using the method described by Laemmli (1970) . HCG radioimmunoassay and antiserum against cyclic AMP were kindly provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Hormone and Pituitary Program (NHPP, Rockville, MD, USA). The 8-bromo adenosine 3Ј,5Ј-cyclic monophosphate (8-Br-cAMP), 2-mercaptoethanol, Sepharose 4B, Tris, glycine, charcoal, Percoll, and bovine serum albumin (BSA) were obtained from Sigma Chemical Co. (St Louis, MO, USA). The gonadotrophinreleasing hormone (GnRH) and GnRH antagonist (Antarelix) were kindly provided by Dr P.Bouchard (Hôpital St Antoine, Paris, France). All reagents for polyacrylamide gel electrophoresis and staining were purchased from Bio-Rad Laboratories (Richmond, CA, USA). Radioinert steroids were obtained from Steraloids Inc. (Wilton, NH, USA). All other chemical reagents and solvents were of analytical grade.
Tissue preparation and cell culture
The study protocol was approved by the Human Ethical Committee of the Institute.
Term placentae (38-42 weeks of gestation) were obtained from normal pregnant women after spontaneous vaginal delivery. Tissues were brought immediately to the laboratory where several cotyledons were removed and rinsed thoroughly in 0.9% NaCl at room temperature. The isolation and culture of cytotrophoblasts was performed as described by Kliman et al. (1986) . Briefly: soft villous tissue (30 g), free of connective tissue and vessels, was collected. Tissue was coarsely minced and digested with 0.125% trypsin (Sigma), and 0.2 mg/ml DNase I (Sigma; 1,500 Kunitz units/mg) in warmed calcium-and magnesium-free Hanks' solution containing 25 mM HEPES, pH 7.4, for 30 min at 37°C. Cell suspensions were pooled, centrifuged at 1000 g for 10 min, and resuspended in Dulbecco's modified Eagle's medium (Gibco, Grand Island, New York, NY, USA) containing 25 mM HEPES and 25 mM glucose (DMEM-HG). The resultant cell suspension was placed on 5-70% Percoll (vol/vol) gradients made up in Hanks' solution. Gradients, which consisted of 5% steps of 3 ml each, were centrifuged at 1200 g at room temperature for 20 min. After centrifugation, the middle band (density 1.048-1.062) containing the cytotrophoblasts was removed, washed once with DMEM-HG, and resuspended in medium for tissue culture. Percoll gradient-purified cytotrophoblasts were diluted to a concentration of 2ϫ10 6 cells/ml with DMEM-HG containing 4 mM glutamine (Sigma), 50 µg/ml gentamicin, and 20% heat-inactivated fetal calf serum (Gibco), plated in 35 mm Nunclon culture dishes (Nunc, Roskilde, Denmark), and incubated in humidified 5% CO 2-95% air at 37°C. After 1 day in culture, or otherwise indicated, cells were incubated in fetal calf serum-free DMEM-HG and media collected every 24 h for 96 h. In all experiments, hormones and proteins were added to cultures after incubation for 48 h. At the end of the incubation period cells were scraped with a rubber policeman and protein content measured by the method of Lowry (1951) , using BSA as standard.
HCG and cAMP assay HCG in culture media from human cytotrophoblasts was measured as previously described (Díaz-Cueto et al., 1994) by specific radioimmunoassay using reagents and protocols provided by the NIDDK and the NHPP. Anti-HCG-H80 (batch 2), at a final working dilution of 1:150 000, was used as antiserum. This antiserum exhibits 1.2% and 3.2% cross-reactivities with free HCG α-and β-subunits, respectively. The sensitivity of the assay was 0.025 ng/tube and the interand intra-assay coefficients of variation were Ͻ10% and Ͻ6%, respectively. Results are shown as the mean (ng/mg cellular protein) Ϯ SE unless specified.
Extracellular cAMP in culture medium was determined by radio- Figure 1 . Effect of 8-Br-cAMP on human chorionic gonadotrophin (HCG) secretion by cultured cytotrophoblasts. Cells were cultured for 96 h in the presence (d) or absence (s) of heat-inactivated fetal calf serum. Cytotrophoblasts in culture were stimulated with the cyclic nucleotide analogue after incubation for 48 h. HCG was quantified by specific radioimmunoassay in the medium at 24 h intervals. Each point represents the mean Ϯ SE from triplicate cultures.
immunoassay using [ 125 I]tyrosil methyl ester of 2Ј-O-monosuccinyladenosine 3Ј,5Ј-cyclic monophosphate (Sigma). Rabbit polyclonal antiserum antibody (NIDDK; CV-27 Pool) was used at a final working dilution of 1:70 000. The assay was performed as described by Knecht et al. (1981) with minor modifications: culture media were boiled at 95°C for 5-10 min to inactivate phosphodiesterase, dried and stored at -20°C until assayed. Acetylation of samples was performed by the addition of 20 µl of a 2:1 solution of triethylamine and acetic anhydride to 0.5 ml of sample. After incubation at 4°C for 24 h, 3 ml of cold pure ethanol was added and radioactivity measured in the precipitates. The sensitivity of the assay was 4 fmol/tube and the inter-and intra-assay coefficients of variation were Ͻ12% and Ͻ6%, respectively.
Statistical analysis
Values are presented as the mean Ϯ SE. All experiments were performed at least three times and each experimental group represented by six to 20 culture wells. Statistical significance was established by one-way analysis of variance and the Walker-Duncan multiple comparison test; P Ͻ 0.05 was considered statistically significant.
Results
HCG secretion
During the 4 days in culture mononuclear cells aggregated and formed syncytia. Percoll-purified cytotrophoblast cells cultured in serum-supplemented medium and stimulated with 1.5 mM 8-Br-cAMP, during the second and third days of culture, responded with a marked ability (96 h) to secrete HCG (1020 ng/mg protein/24 h) (Figure 1 ). Cytotrophoblasts plated in serum-free medium had considerably less capacity to synthesize and secrete HCG (270 ng/mg protein/24 h) in response to stimulation with the cyclic nucleotide analogue during the same time culture periods (48 h and 72 h). The control cells secreted Ͻ30 ng/mg protein/24 h during the first 48 h with a progressive increase in HCG secretion after 72 and 96 h of culture. In addition to cAMP and in order to assess whether our Figure 2 . Effects of gonadotrophin-releasing hormone (GnRH) on human chorionic gonadotrophin (HCG) secretion by cultured cytotrophoblasts. After 1 day, cultured cells were incubated in serum-free media containing GnRH at two different concentrations for 2 consecutive days. Media were changed at 24 h intervals and at the end of the incubation period (96 h) HCG was measured by specific radioimmunoassay in the culture medium. Each bar represents the mean Ϯ SE from triplicate cultures. GnRH-treated cultures secreted significantly more (P Ͻ 0.001) than nonstimulated controls.
human full-term placental cells could respond to other wellknown HCG release stimulators, we incubated cytotrophoblast cells in serum-free medium with two different concentrations of GnRH (15 and 30 nM). GnRH was added during the second and third days of culture and responses in terms of HCG secreted into culture media were recorded on day 4. As shown in Figure 2 , addition of GnRH to placental cells induced a significant increase of HCG (P Ͻ 0.001 versus basal) in culture media. This effect on HCG secretion was similar to that observed with serum-free placental cells cultured in the presence of 8-Br-cAMP and blocked when co-incubated in the presence of Antarelix, a GnRH antagonist (data not shown). Thus, term human placental cells cultured in serum-free medium under the conditions described herein had an adequate biochemical response to these two different HCG stimulators.
Effects of human SHBG and steroids on basal HCG release
The human SHBG utilized throughout this study was purified from serum of pregnant women during pregnancy or at the time of delivery. The analysis of purified human SHBG by SDS-PAGE using a silver stain with a sensitivity of~10 ng of protein revealed a very pure, homogeneous SHBG preparation (Figure 3 ). The final preparation had a specific activity 2800-fold over that of serum with an overall recovery of~20-25%. Figure 4 shows the time courses of daily HCG release into the medium from term placental cell cultures in the presence or absence of human SHBG. Addition of serum-free medium containing 1 nM of human SHBG alone after 48 h of culture increased significantly (P Ͻ 0.005) the concentration of HCG in culture media on day 3. At this time, cells were rinsed and further incubated in fresh serum and human SHBG-free medium in the presence or absence of either 10 nM oestradiol or DHT. As depicted in Figure 4 , exposure to these steroids furthermore increased the secretion of HCG into the culture medium (P Ͻ 0.005 versus 72 h). Those cells incubated in the absence of steroids did not show any significant effect on HCG secretion when compared to only human SHBGstimulated cultures; however, their HCG concentrations in culture media on day 4 (94 Ϯ 8 ng/mg protein) still remained significantly (P Ͻ 0.005) higher than those of control (C) nonstimulated cells (32 Ϯ 6 ng/mg protein).
Effects of human SHBG and SHBG-steroid complexes on cAMP production
As mentioned before, incubations of placental cells in the presence of human SHBG alone increased the secretion of HCG and addition of biologically active steroids (oestradiol and DHT) further increased its concentrations in culture media. In order to evaluate if this effect was coupled to stimulation of adenylate cyclase, we next investigated the effects of human SHBG on cAMP accumulation prior and after the addition of steroid hormones. As shown in Figure 5 , human SHBG alone at 10 -9 M elicited the greatest increase in HCG secretion. The effect was evaluated in media from 4 day cultures incubated in the presence of various concentrations of human SHBG during the second and third days of culture, respectively. As noticed, the major response in terms of cAMP accumulation was also observed at a human SHBG final concentration of 10 -9 M. In all cases, addition of higher concentrations of this protein did not increase further HCG and cAMP accumulation. Figure 6 shows the effects of oestradiol and DHT on HCG and cAMP. Steroids were added (10 nM final concentration) to cells (72 h of culture) after 24 h incubation with human SHBG (1 nM). As depicted, both steroids induced a significant Figure 7 . Effects of human sex hormone-binding globulin (SHBG) previously saturated with dihydrotestosterone (human SHBG-DHT) and steroids alone on human chorionic gonadotrophin (HCG) secretion by cultured cytotrophoblasts. Cells were incubated in the presence or absence (control) of human SHBG with (human SHBGϩDHT) or without (human SHBG) the sequential addition of DHT, human SHBG-DHT complexes (human SHBG-DHT) or steroids alone (oestradiol, DHT) as described above. At the end of the incubation period, HCG in culture media was measured by specific radioimmunoassay. Each bar represents the mean Ϯ SE of triplicate cultures. *P Ͻ 0.005 versus control, human SHBG-DHT, oestradiol and DHT. **P Ͻ 0.005 versus human SHBG. increase in both HCG and cAMP concentrations (P Ͻ 0.005 versus control in the absence of steroids). Although both steroids produced a similar increase on HCG, DHT appeared to be more efficient than oestradiol in terms of cAMP accumulation.
Since a significant increase in HCG and cAMP was obtained with 1 nM human SHBG plus 10 nM oestradiol or DHT (1:10 molar ratio), we repeated a similar experiment but adding to the cultures 1 nM human SHBG previously incubated with 10 nM DHT. The exposure to human SHBG-DHT complexes did not affect HCG secretion by cultured placental cells. Similarly, addition of 10 nM oestradiol or DHT alone had no effect on the basal secretion of HCG by these cells ( Figure  7 ). In addition, incubations in the presence of human prolactin (1 and 10 nM) did not modify the secretion of HCG by placental cells cultured in the presence or absence of serumcontaining media (not shown).
Discussion
In this study, we have described and presented evidence that human SHBG induces HCG secretion in cultured human syncytiotrophoblasts. In addition, when placental cells were cultured in the presence of human SHBG followed by the exposure of oestradiol or DHT a further increase in HCG concentration was observed. We also showed that the increase in HCG secretion by human SHBG alone or following the addition of steroids after incubation with human SHBG was associated with accumulation of cAMP. These results are consistent with previous observations on the presence of specific human SHBG binding sites in human syncytiotrophoblast membranes (Krupenko et al., 1990) and strongly support the hypothesis that the SHBG receptor is part of the G-protein receptor family.
It is well known that human SHBG markedly increases during pregnancy, probably due in part to the increase in circulating oestrogens (Anderson, 1974) . The presence of human SHBG in amniotic fluid has largely been recognized (Caputo and Hosty, 1972) , but the exact origin and the reasons for the existence and function of this protein in amniotic fluid are still not fully understood. In this regard, it is of interest that increased serum human SHBG concentrations have been observed in women with either hydatidiform mole and choriocarcinoma (Wenn et al., 1977) which, together with the suggestion made in the late 1970s that measurements of this protein might provide, in addition to HCG, a reliable index for the prognosis of trophoblast disorders, could suggest the possibility that placenta may synthesize SHBG. Indeed, we have recently demonstrated in human term placenta the presence of SHBG mRNA and a protein with similar structural, immune and binding characteristics to that found in human serum (Larrea et al., 1993) .
The presence of SHBG in blood and its increase in both maternal serum and amniotic fluid regardless of the origin of this protein during pregnancy are not fully understood. In this study, the ability of human SHBG to stimulate both HCG and cAMP could be of physiological significance, especially when considering the placenta as a target for sex steroids (Younes et al., 1981) . It has been recognized that SHBG has the ability to activate cellular metabolism by acting on the cell surface (Mercier-Bodard et al., 1976) , and the first high affinity binding sites for SHBG were reported on membranes from human decidual endometrium (Strel'chyonok et al., 1984) . Thereafter, a number of studies showed that androgen-binding protein and SHBG interact with proteins in plasma membranes of steroid target tissues (Fortunati et al., 1991; Hryb et al., 1990; Porto et al., 1992) , including human placenta (Krupenko et al., 1990) . In some studies but not in others (Porto et al., 1995) , the SHBG-receptor complex functions fully only when the steroid hormone binds to the complex. Herein, we demonstrated that human SHBG alone was able to increase significantly both HCG and cAMP above basal concentrations, indicating that in placenta as in the case of MCF-7 breast cancer cells (Porto et al., 1995) ligand-free human SHBG activates the receptor-adenylate cyclase system. The reasons for this discrepancy are not clear but otherwise may indicate differences in experimental approaches, especially those regarding human SHBG concentrations; moreover, it might reflect tissue differences in structural and physicochemical characteristics among receptors. However, the mechanisms determining HCG and cAMP accumulation induced by human SHBG alone need further clarification and must await purification and characterization of the receptors and cloning of their cDNA. In terms of receptor-effector coupling specificity, whether ligand-induced increases in cAMP can be caused by factors other than receptormediated activation of adenylate cyclase is still unknown and needs further clarification, and otherwise is being investigated in our laboratory. It should be pointed out that proliferative cell activity in our cultures could be due in part to the increase 1372 of HCG (Kiss et al., 1997) observed in the absence of SHBG but in any case the increments were significant.
In line with the allosteric model for SHBG binding proposed by Hryb et al. (1990) , we could demonstrate a significant enhancing effect on HCG and cAMP when either oestradiol or DHT was added to cells whose receptors were occupied by human SHBG. In contrast, there was no stimulation of basal HCG and cAMP when cells were exposed to human SHBG previously saturated with DHT. These observations further support the concept that SHBG functions as an allosteric protein whose membrane-binding site is masked when its steroid-binding site is occupied. Investigations of the effects of steroids on HCG secretion have yielded contradictory results (Wilson et al., 1980; Zeitler et al., 1983; Barnea and Kaplan, 1989; Rao et al., 1995) . In the case of progesterone the differences are probably related to the concentrations of hormone used. In contrast, as in the case of our study, androgens and oestrogens by themselves do not influence the secretion of HCG (Wilson et al., 1980; Zeitler et al., 1983) .
The biological action of HCG in the initiation and maintenance of human pregnancy emphasizes the potential importance of human SHBG among other factors such as GnRH, activin and inhibin (Siler-Khodr and Khodr, 1981; Petraglia et al., 1987 Petraglia et al., , 1989 . Moreover, because steroid hormones modulate cell growth and differentiation in a number of tissues, a possible role of placental SHBG on placental-fetal growth, including trophoblast differentiation and hormone secretion, could also be proposed. In addition, our results do not exclude the possibility for functional differences in secretory activity between the first trimester and term trophoblasts. The factors involved in governing the typical pattern of maternal plasma HCG concentration throughout pregnancy are still unknown, but may depend on the equilibrium of a number of stimulatory factors, with peak values during the first trimester and stable concentrations or even the presence of inhibitory influences in the remaining part of gestation. Further studies are needed regarding the effects of SHBG on placental HCG at different stages of development. On the other hand, molecular heterogeneity of HCG has been involved in determining the circulatory survival of the hormone which may be partially caused by changes in the carbohydrate composition (Díaz-Cueto et al., 1996) . Although the factors involved in the regulation of HCG glycosylation are unknown, changes in the secretion of sex steroids and other non-steroidal factors have been established for luteinizing hormone and follicle stimulating hormone (Phillips and Wide, 1994; Ulloa-Aguirre et al., 1995) . Whether SHBG regulates HCG secretion through steroid mediated modifications in glycosylation patterns remains to be determined.
In conclusion, our results demonstrate the ability of human SHBG alone or sequentially incubated with oestradiol and DHT to stimulate HCG release and cAMP accumulation from cultured human syncytiotrophoblasts. These results are compatible with the earlier description of SHBG binding sites in placental membranes and support the concept that SHBG might function as a regulator of cellular functions through membrane receptors that are functionally coupled to adenylate cyclase.
